Siemens Highlights Presents Latest Breakthroughs in Healthcare
|
By LabMedica International staff writers Posted on 03 Feb 2025 |

Siemens Healthineers (Forchheim, Germany) is presenting its transformative healthcare solutions at Medlab Middle East 2025 that are designed to empower professionals to provide the highest level of care to their patients.
Siemens is highlighting various products highlighted including its two new high-volume hematology analyzers, the Atellica HEMA 570 and 580. Designed to meet the hematology testing needs of today’s high-volume labs, both instruments share fast throughput and an identical footprint. Also featured at the event is the IMMULITE 2000 XPi immunoassay system that provides multiple tests on a single, easy-to-use analyzer. This makes it simple to adjust to changes in demand and scale capabilities without disrupting day-to-day operations. Additionally, Siemens is presenting the CN-3000 and CN-6000 coagulation designed to meet the small-sized, mid- and high-volume hemostasis testing solutions. The CN Systems leverage optical testing methodology with intelligent software to automate and standardize sample management for reliable results, reduced repeat testing, and reagent waste. Siemens is also highlighting Atellica Integrated Automation which consolidates revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.
Among its compact solutions featured at the event is the Atellica DCA Analyzer which puts fast, quality HbA1c and ACR results right at the fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization required to boost efficiencies and meet growing demand, the Atellica DCA Analyzer can be placed wherever it is needed when space is at a premium. Also featured at the event is the RAPIDPoint 500e System that elevates Siemens’ blood gas offering to a new level. This end-to-end blood gas solution reduces the daily burden of device management and enables healthcare professionals to give full care and attention to their patients. Moreover, Siemens is also demonstrating the Atellica VTLi patient-side immunoassay analyzer for high-sensitivity troponin testing at the point of care. It produces accurate results in just 8 minutes, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.
Latest MEDLAB 2025 News
- Medlab Middle East Rebranded to WHX Labs Dubai
- BIOBASE Showcases Comprehensive Range of Laboratory Solutions
- Dymind Presents Advanced Automatic Hematology Analysis Line
- BioPerfectus Presents Latest Solutions for Women's Health and Infectious Disease Diagnosis
- YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency
- Vazyme Showcases Cutting-Edge Microfluidic Solutions for Precise and Efficient Laboratory Workflows
- Erba Unveils New H 7100 Advanced Hematology Analyzer
- HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments
- Tianlong Presents Advanced Instruments and Cutting-Edge Reagents
- Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes
- DRG Unveils Innovative Traumatic Brain Injury (TBI) Test Panel
- Fapon Presents Comprehensive Range of One-Stop IVD Solutions
- Anbio Biotechnology Showcases Cutting-Edge Diagnostic Solutions
- Sysmex Showcases Latest Laboratory Innovations and Technologies
- Sansure Presents Advanced Diagnostic Solutions
- Snibe Demonstrates Cutting-Edge Diagnostic Solutions
Channels
Clinical Chemistry
view channel
New Blood Biomarker Predicts May Predict Preeclampsia and Fetal Growth Restriction
Preeclampsia and fetal growth restriction are major drivers of stillbirth and serious maternal morbidity, yet clinicians still lack reliable early predictors to guide targeted surveillance.... Read more
Biomarker Score Helps Differentiate Takotsubo Syndrome from Myocardial Infarction
Takotsubo syndrome, often called broken-heart syndrome, mimics myocardial infarction and can be difficult to triage in emergency settings. It accounts for about 2% of suspected heart attacks and up to... Read moreMolecular Diagnostics
view channel
Automated System Streamlines DNA Recovery for MRD-Sensitive Testing
Molecular laboratories are under pressure to detect extremely low levels of residual disease, yet pre-analytical recovery of cell-free and genomic DNA from large-volume blood and plasma remains a persistent... Read more
New Liquid Biopsy Platform Uses Red Blood Cells to Detect Hidden Cancer Signals
Plasma-based liquid biopsy can miss clinically actionable tumor signals, particularly in early-stage disease and low-shedding tumors, limiting its utility for routine monitoring. Clinical laboratories... Read moreHematology
view channel
New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome
Inherited bone marrow failure syndromes (IBMFS) impair the bone marrow’s ability to produce sufficient healthy blood cells and are associated with an increased risk of early-onset myelodysplastic syndromes (MDS).... Read more
Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
Patients who need frequent blood tests often face repeated clinic visits that burden services and disrupt care. In the UK, millions of tests are performed each year to diagnose disease, guide therapy,... Read moreImmunology
view channel
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read moreMicrobiology
view channel
Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification
Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours
Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read morePathology
view channel
Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples
Peripheral blood mononuclear cells (PBMCs) are widely used to monitor infection, autoimmunity, cancer, and treatment response, yet most assays depend on fluorescent labels that can perturb cells and provide... Read more
AI Tool Improves Prediction of Immunotherapy Response in Lung Cancer
Immune checkpoint therapies benefit only a subset of patients, while standard biomarkers often struggle to predict who will respond. Spatially resolved tumor profiling can provide deeper biological context,... Read moreTechnology
view channel
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read more
Autonomous Robotic System Receives FDA Authorization for Blood Collection
Venipuncture is central to many diagnostic pathways, but routine blood collection can be affected by staffing constraints and procedural variability that influence consistency and patient experience.... Read moreIndustry
view channel
New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
Rapid and accurate classification of central nervous system tumors remains a challenge, particularly in children where histology alone can misclassify aggressiveness and drive overtreatment.... Read more








